speb/financial-data huggingface dataset:
Financial ratios for SNWV — quarterly report dated 2025-12-31
Total revenue: 13094000
Gross profit: 9702000
Operating income: 615000
Net income: 6109000
Capital expenditures: 96000
Operating cash flow: 3319000
Depreciation & amortization: 649000
Net tangible assets: -8667000
Owner earnings: 6662000
Return on net tangible assets (%): -76.86627437406254
Capex to operating income (%): 15.609756097560975
Buffett classification: The Great
Stock price: 29.84
P/E ratio: 22.565600548764397
Shares outstanding: 8598976
Book value: 1619000
P/B ratio: 158.48884733786286
Market cap (USD): 256593443.84
Debt to equity: 14.18838789376158
Current ratio: 1.3798957808034964
Quick ratio: 1.0474029248613212
Interest coverage ratio: 0.7706766917293233
COGS to revenue (%): 25.90499465404002
R&D to revenue (%): 4.628073926989461
SG&A to revenue (%): 62.540094699862536
Free cash flow (dilution-adjusted): 1886000
Buyback yield (%): 0
Retained earnings: -242685000
Inventory turnover: 0.5716211661611055
Receivables turnover: 2.414976023607525
Capitalized R&D asset: 901170
ROCI (R&D-adjusted, %): 4.114949933413965
Rosenberg metric: 2.252173913043478
FCF margin (%): 14.403543607759278
Revenue growth (%): 14.348091869705703
Rule of 40 score: 28.75163547746498
Financial ratios for SNWV — annual report dated 2025-12-31
Total revenue: 44051000
Gross profit: 33969000
Operating income: 4945000
Net income: 11813000
Capital expenditures: 1942000
Operating cash flow: 3876000
Depreciation & amortization: 1283000
Net tangible assets: -8667000
Owner earnings: 11154000
Return on net tangible assets (%): -128.69505019037732
Capex to operating income (%): 39.27199191102123
Buffett classification: The Good
Stock price: 29.84
P/E ratio: 21.721276884787947
Shares outstanding: 8598976
Book value: 1619000
P/B ratio: 158.48884733786286
Market cap (USD): 256593443.84
Debt to equity: 14.18838789376158
Current ratio: 1.3798957808034964
Quick ratio: 1.0474029248613212
Effective tax rate (%): 0.7227498109084798
Interest coverage ratio: 0.7917066922830611
COGS to revenue (%): 22.887108124673674
R&D to revenue (%): 3.0714399219086967
SG&A to revenue (%): 60.81814260743229
Free cash flow (dilution-adjusted): -2916000
Buyback yield (%): 0
Retained earnings: -242685000
Inventory turnover: 1.6990225817323896
Receivables turnover: 8.124492807082257
Capitalized R&D asset: 1994980
ROCI (R&D-adjusted, %): 25.264863057276433
Rosenberg metric: 13.99554234769688
FCF margin (%): -6.619600009080385
Revenue growth (%): 34.98498498498498
Rule of 40 score: 28.365384975904597
Financial ratios for SOMATEX.NS — annual report dated 2022-03-31
Total revenue: 1841302.9144138205
Gross profit: 79928.78807859686
Operating income: -776618.7524726362
Net income: -2165027.0341553474
Capital expenditures: 823315.3105631017
Operating cash flow: 4364499.53844125
Depreciation & amortization: 115798.49663721482
Net tangible assets: -11314031.38599499
Owner earnings: -2872543.848081234
Buffett classification: The Gruesome
Stock price: 0.09587234603718844
Shares outstanding: 33033000
Book value: -11303903.46828432
Market cap (USD): 3166951.2066464457
Debt to equity: -1.211358240732639
Current ratio: 0.35678229843964765
Quick ratio: 0.3492931767521027
Interest coverage ratio: -0.3140853333333333
COGS to revenue (%): 95.65911792932549
SG&A to revenue (%): 1.699540200249237
Free cash flow (dilution-adjusted): 4338652.248450481
Buyback yield (%): 0
Retained earnings: -28324713.17420546
Inventory turnover: 12.701122099657665
Receivables turnover: 181.09727626459144
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -53.028679483138994
FCF margin (%): 235.62946729119219
Rule of 40 score: 235.62946729119219
Financial ratios for SOMATEX.NS — annual report dated 2023-03-31
Total revenue: 583580.9987819733
Gross profit: -16126.674786845311
Operating income: -573032.886723508
Net income: 20153252.131546896
Capital expenditures: 985030.4506699148
Operating cash flow: 20735054.81120585
Depreciation & amortization: 63702.80146163216
Net tangible assets: 9143568.818514008
Owner earnings: 19231924.482338615
Return on net tangible assets (%): 210.3328018201994
Buffett classification: The Gruesome
Stock price: 0.4498172959805116
P/E ratio: 0.7372911647775692
Shares outstanding: 33033000
Book value: 9152789.281364191
P/B ratio: 1.6234192967140597
Market cap (USD): 14858814.73812424
Debt to equity: 0.06322227604452227
Current ratio: 2.120390139751553
Quick ratio: 1.994225543478261
Effective tax rate (%): 1.0779553643973405
Interest coverage ratio: -0.5823173373271776
COGS to revenue (%): 102.76339956587077
SG&A to revenue (%): 2.7320921689764566
Free cash flow (dilution-adjusted): 20733081.607795373
Buyback yield (%): 0
Retained earnings: -6568136.419001219
Inventory turnover: 18.93692307692308
Receivables turnover: 2.5424250464314144
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.544078879918358
FCF margin (%): 3552.7341793287687
Revenue growth (%): -68.30608401183373
Rule of 40 score: 3484.428095316935
Financial ratios for SOMATEX.NS — annual report dated 2024-03-31
Total revenue: 686749.0106727425
Gross profit: -4592.876843746252
Operating income: -442283.24739177356
Net income: 2529356.0378942317
Capital expenditures: 2502626.2141743614
Operating cash flow: 3109413.598752848
Depreciation & amortization: 38565.775272814484
Net tangible assets: 10607135.148099292
Owner earnings: 65295.598992684856
Return on net tangible assets (%): 0.6155818520365065
Buffett classification: The Gruesome
Stock price: 0.40115163147792704
P/E ratio: 5.2389784767677225
Shares outstanding: 33033000
Book value: 10616045.089339249
P/B ratio: 1.2482277280375729
Market cap (USD): 13251241.842610365
Debt to equity: 0.018344644357892265
Current ratio: 1.831516385214789
Quick ratio: 1.831516385214789
Effective tax rate (%): 12.530221409406273
Interest coverage ratio: -7.329491255961844
COGS to revenue (%): 100.66878536006148
SG&A to revenue (%): 2.80610463085842
Free cash flow (dilution-adjusted): 2828000.9593476434
Buyback yield (%): 8.823361270795754
Retained earnings: -3933121.477395371
Receivables turnover: 3.3334109429569265
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.094283300603784
FCF margin (%): 411.7954180345044
Revenue growth (%): 17.678439172299534
Rule of 40 score: 429.4738572068039
Financial ratios for SOMATEX.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 18852126.13473483
Buffett classification: The Gruesome
Stock price: 0.5176779741997134
Shares outstanding: 33033000
Book value: 18860487.33874821
P/B ratio: 0.9066815832805573
Market cap (USD): 17100456.521739133
Debt to equity: 0.009436352121595947
Current ratio: 92.00970873786407
Quick ratio: 92.00970873786407
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SOMATEX.NS — quarterly report dated 2024-12-31
Total revenue: 68772.58421727474
Gross profit: 1165.6370206317752
Operating income: -234293.0411469868
Net income: -39631.65870148036
Capital expenditures: 0
Depreciation & amortization: 9325.096165054201
Owner earnings: -30306.562536426158
Buffett classification: The Gruesome
Stock price: 0.5440027975288495
Shares outstanding: 33033000
Market cap (USD): 17970044.410770487
Interest coverage ratio: -67
COGS to revenue (%): 98.3050847457627
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SOMATEX.NS — annual report dated 2025-03-31
Total revenue: 1109130.2314706568
Gross profit: 14788.403086275426
Operating income: -725531.9148936169
Net income: 8097813.88823942
Capital expenditures: 7725379.939209726
Operating cash flow: -697287.8185644143
Depreciation & amortization: 48608.837970540095
Net tangible assets: 18443277.998597145
Owner earnings: 421042.78700023424
Return on net tangible assets (%): 2.2829064715733294
Buffett classification: The Gruesome
Stock price: 0.43727389427004315
P/E ratio: 1.7837491388139037
Shares outstanding: 33033000
Book value: 18451788.63689502
P/B ratio: 0.7828221335973954
Market cap (USD): 14444468.549422335
Debt to equity: 0.018431086325985224
Current ratio: 71.59352030257618
Quick ratio: 71.59352030257618
Effective tax rate (%): -1.4454824645549247
Interest coverage ratio: -38.71615720524017
COGS to revenue (%): 98.66666666666669
SG&A to revenue (%): 0.6956521739130435
Free cash flow (dilution-adjusted): -1018950.1987374327
Buyback yield (%): 0
Retained earnings: 4268307.224690204
Receivables turnover: 3.1378158486572296
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.87110617379746
FCF margin (%): -91.86930171277999
Revenue growth (%): 61.50445275256352
Rule of 40 score: -30.364848960216463
Financial ratios for SOMATEX.NS — quarterly report dated 2025-03-31
Total revenue: 452419.9205050269
Gross profit: 9352.349777881693
Operating income: -195230.30161328032
Net income: 28057.049333645075
Capital expenditures: 0
Depreciation & amortization: 15197.56838905775
Net tangible assets: 18443277.998597145
Owner earnings: 43254.617722702824
Return on net tangible assets (%): 0.23452781943639794
Buffett classification: The Gruesome
Stock price: 0.43727389427004315
P/E ratio: 128.70623330391527
Shares outstanding: 33033000
Book value: 18451788.63689502
P/B ratio: 0.7828221335973954
Market cap (USD): 14444468.549422335
Debt to equity: 0.018431086325985224
Current ratio: 71.59352030257618
Quick ratio: 71.59352030257618
Interest coverage ratio: -27.833333333333336
COGS to revenue (%): 97.9328165374677
Buyback yield (%): 0
Retained earnings: 4268307.224690204
Receivables turnover: 1.279931207831724
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.0416595195516996
Revenue growth (%): 557.8492369512925
Rule of 40 score: 557.8492369512925
Financial ratios for SOMATEX.NS — quarterly report dated 2025-06-30
Total revenue: 239878.30564006555
Gross profit: 4680.552305172011
Operating income: -290194.24292066466
Net income: 424760.12169436
Capital expenditures: 0
Depreciation & amortization: 16381.933068102036
Owner earnings: 441142.05476246204
Buffett classification: The Gruesome
Stock price: 0.5100631874561199
P/E ratio: 40.77809305647424
Shares outstanding: 33033000
Market cap (USD): 16848917.271238007
Effective tax rate (%): 0
Interest coverage ratio: -41.333333333333336
COGS to revenue (%): 98.04878048780488
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -46.978836525965875
Rule of 40 score: -46.978836525965875
Financial ratios for SOMATEX.NS — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: 0
Operating income: -357384.44193912065
Net income: -71025.93010146561
Capital expenditures: 0
Depreciation & amortization: 9019.165727170237
Net tangible assets: 18125140.924464487
Owner earnings: -62006.76437429537
Return on net tangible assets (%): -0.34210362629843877
Buffett classification: The Gruesome
Stock price: 0.8177001127395715
P/E ratio: 78.94295301763444
Shares outstanding: 33033000
Book value: 18133032.694475763
P/B ratio: 1.4896067458343696
Market cap (USD): 27011087.824126266
Debt to equity: 0.0018652076597861227
Current ratio: 40.43928571428572
Quick ratio: 40.43928571428572
Interest coverage ratio: -79.25
Buyback yield (%): 0
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.9650384329283412
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for SOMATEX.NS — quarterly report dated 2025-12-31
Total revenue: 3120196.056589061
Gross profit: 634955.9986632506
Operating income: 28962.90520218336
Net income: 216107.83112398352
Capital expenditures: 0
Depreciation & amortization: 3341.8736771750027
Owner earnings: 219449.7048011585
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.5955218892725855
P/E ratio: 88.15011936310165
Shares outstanding: 33033000
Market cap (USD): 52704874.568341315
Effective tax rate (%): 0
COGS to revenue (%): 79.65012495537309
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SPB — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 85.39
Shares outstanding: 22995596
Market cap (USD): 1963593942.44
Buyback yield (%): 0
Capitalized R&D asset: 29800000
Rule of 40 score: 0
Financial ratios for SPB — annual report dated 2022-09-30
Total revenue: 3132500000
Gross profit: 990400000
Operating income: -5300000
Net income: 72700000
Capital expenditures: 63800000
Operating cash flow: -53800000
Depreciation & amortization: 99300000
Net tangible assets: -892100000
Owner earnings: 108200000
Return on net tangible assets (%): -12.128685124985989
Buffett classification: The Gruesome
Stock price: 35.52
P/E ratio: 11.235262309766163
Shares outstanding: 22995596
Book value: 1269100000
P/B ratio: 0.6436085177842565
Market cap (USD): 816803569.9200001
Debt to equity: 2.531557796863919
Current ratio: 2.723087282215302
Quick ratio: 2.066071879471425
Interest coverage ratio: -0.05331991951710262
COGS to revenue (%): 68.38308060654428
R&D to revenue (%): 0.8523543495610535
SG&A to revenue (%): 31.78611332801277
Free cash flow (dilution-adjusted): -128000000
Buyback yield (%): 16.40541311702694
Retained earnings: 362100000
Inventory turnover: 2.7441711503971304
Receivables turnover: 9.129991256193529
Capitalized R&D asset: 46666000
ROCI (R&D-adjusted, %): 0.05538572996018416
FCF margin (%): -4.086193136472466
Rule of 40 score: -4.086193136472466
Financial ratios for SPB — annual report dated 2023-09-30
Total revenue: 2918800000
Gross profit: 924300000
Operating income: 35500000
Net income: 1801900000
Capital expenditures: 50600000
Operating cash flow: -409700000
Depreciation & amortization: 91200000
Net tangible assets: 602800000
Owner earnings: 1842500000
Return on net tangible assets (%): 305.6569343065693
Capex to operating income (%): 142.53521126760563
Buffett classification: The Gruesome
Stock price: 73.18
P/E ratio: 0.9339129337255121
Shares outstanding: 22995596
Book value: 2518300000
P/B ratio: 0.6682356015089546
Market cap (USD): 1682817715.2800002
Debt to equity: 0.6556407100027797
Current ratio: 3.8257060669456067
Quick ratio: 3.2205805439330546
Interest coverage ratio: 0.305770887166236
COGS to revenue (%): 68.33287652459916
R&D to revenue (%): 0.7708647389338085
SG&A to revenue (%): 30.45087022063862
Free cash flow (dilution-adjusted): -485900000
Buyback yield (%): 31.77408908552121
Retained earnings: 2096000000
Inventory turnover: 4.309636992221262
Receivables turnover: 5.197293447293447
Capitalized R&D asset: 50223000
ROCI (R&D-adjusted, %): 0.6969168179893158
Rosenberg metric: -2.4756554307116105
FCF margin (%): -16.647252295463886
Revenue growth (%): -6.822027134876296
Rule of 40 score: -23.469279430340183
Financial ratios for SPB — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 90.68
Shares outstanding: 22995596
Market cap (USD): 2085240645.2800002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SPB — annual report dated 2024-09-30
Total revenue: 2963900000
Gross profit: 1109300000
Operating income: 155900000
Net income: 124800000
Capital expenditures: 44000000
Operating cash flow: 162600000
Depreciation & amortization: 101800000
Net tangible assets: 285600000
Owner earnings: 182600000
Return on net tangible assets (%): 63.93557422969187
Capex to operating income (%): 28.223220012828737
Buffett classification: The Good
Stock price: 90.68
P/E ratio: 16.70865901666667
Shares outstanding: 22995596
Book value: 2141700000
P/B ratio: 0.9736380656861373
Market cap (USD): 2085240645.2800002
Debt to equity: 0.3170845589951907
Current ratio: 2.2974821714452043
Quick ratio: 1.6249454227914424
Effective tax rate (%): 39.30317848410758
Interest coverage ratio: 2.664957264957265
COGS to revenue (%): 62.57296130098856
SG&A to revenue (%): 32.167077161847565
Free cash flow (dilution-adjusted): 101100000
Buyback yield (%): 23.14840740768241
Retained earnings: 2169000000
Inventory turnover: 4.013417009305345
Receivables turnover: 4.197564084407308
Capitalized R&D asset: 23886000
ROCI (R&D-adjusted, %): 4.3880536732884865
Rosenberg metric: 8.222222222222221
FCF margin (%): 3.411046256621344
Revenue growth (%): 1.5451555433739894
Rule of 40 score: 4.956201799995333
Financial ratios for SPB — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 80.94
Shares outstanding: 22995596
Market cap (USD): 1861263540.24
Buyback yield (%): 0
Capitalized R&D asset: 5700000
Rule of 40 score: 0
Financial ratios for SPB — quarterly report dated 2025-03-31
Total revenue: 675700000
Gross profit: 253400000
Operating income: 41400000
Net income: 1200000
Capital expenditures: 9200000
Operating cash flow: 23100000
Depreciation & amortization: 24500000
Net tangible assets: 78800000
Owner earnings: 16500000
Return on net tangible assets (%): 20.939086294416242
Capex to operating income (%): 22.22222222222222
Buffett classification: The Great
Stock price: 68.96
P/E ratio: 330.3700625333333
Shares outstanding: 22995596
Book value: 1885300000
P/B ratio: 0.8411267703601548
Market cap (USD): 1585776300.1599998
Debt to equity: 0.3796743223890097
Current ratio: 2.3430465887279706
Quick ratio: 1.3962659221776303
Effective tax rate (%): 84.21052631578947
Interest coverage ratio: 5.52
COGS to revenue (%): 62.4981500665976
R&D to revenue (%): 0.8731685659316264
SG&A to revenue (%): 30.501701938730207
Free cash flow (dilution-adjusted): 8700000
Buyback yield (%): 10.083389440482026
Retained earnings: 2167300000
Inventory turnover: 0.778289716181349
Receivables turnover: 1.0308161708619374
Capitalized R&D asset: 9719000
ROCI (R&D-adjusted, %): 1.4606220007786248
FCF margin (%): 1.2875536480686696
Rule of 40 score: 1.2875536480686696
Financial ratios for SPB — quarterly report dated 2025-06-30
Total revenue: 699600000
Gross profit: 264100000
Operating income: 45800000
Net income: 19900000
Capital expenditures: 10000000
Operating cash flow: 81800000
Depreciation & amortization: 25100000
Net tangible assets: 72900000
Owner earnings: 35000000
Return on net tangible assets (%): 48.010973936899866
Capex to operating income (%): 21.83406113537118
Buffett classification: The Great
Stock price: 51.5
P/E ratio: 56.126691658767776
Shares outstanding: 22995596
Book value: 1893800000
P/B ratio: 0.6253422716231914
Market cap (USD): 1184273194
Debt to equity: 0.4012567324955117
Current ratio: 2.4207195805460135
Quick ratio: 1.5031639848128728
Effective tax rate (%): 6.8181818181818175
Interest coverage ratio: 5.4523809523809526
COGS to revenue (%): 62.24985706117781
R&D to revenue (%): 0.7861635220125787
SG&A to revenue (%): 30.417381360777583
Free cash flow (dilution-adjusted): 67000000
Buyback yield (%): 4.5935346907801415
Retained earnings: 2175300000
Inventory turnover: 0.858128078817734
Receivables turnover: 1.0563188887211235
Capitalized R&D asset: 11334000
ROCI (R&D-adjusted, %): 1.5197294881511092
Rosenberg metric: 1.8135593220338984
FCF margin (%): 9.576901086335049
Revenue growth (%): 3.537072665384046
Rule of 40 score: 13.113973751719094
Financial ratios for SPB — quarterly report dated 2025-09-30
Total revenue: 733500000
Gross profit: 256600000
Operating income: 12100000
Net income: 55700000
Capital expenditures: 13200000
Operating cash flow: 171100000
Depreciation & amortization: 23900000
Net tangible assets: 105300000
Owner earnings: 66400000
Return on net tangible assets (%): 63.0579297245964
Capex to operating income (%): 109.09090909090908
Buffett classification: The Gruesome
Stock price: 51.47
P/E ratio: 15.411241225520833
Shares outstanding: 22995596
Book value: 1909700000
P/B ratio: 0.619774480871341
Market cap (USD): 1183583326.12
Debt to equity: 0.34256689532387286
Current ratio: 2.263379204892966
Quick ratio: 1.4107415902140672
Effective tax rate (%): -206.32183908045977
Interest coverage ratio: 1.5316455696202531
COGS to revenue (%): 65.01704158145876
SG&A to revenue (%): 35.66462167689161
Free cash flow (dilution-adjusted): 152100000
Buyback yield (%): 3.3119763632109187
Retained earnings: 2219300000
Inventory turnover: 1.069042815512217
Receivables turnover: 1.2809989521480964
Capitalized R&D asset: 5632000
ROCI (R&D-adjusted, %): 0.2900037455905455
Rosenberg metric: -1.3636363636363635
FCF margin (%): 20.736196319018404
Revenue growth (%): 4.845626072041166
Rule of 40 score: 25.58182239105957
Financial ratios for SPB — annual report dated 2025-09-30
Total revenue: 2809000000
Gross profit: 1031900000
Operating income: 149300000
Net income: 100400000
Capital expenditures: 38300000
Operating cash flow: 203600000
Depreciation & amortization: 98000000
Net tangible assets: 105300000
Owner earnings: 160100000
Return on net tangible assets (%): 152.0417853751187
Capex to operating income (%): 25.653047555257867
Buffett classification: The Good
Stock price: 51.47
P/E ratio: 11.788678547011953
Shares outstanding: 22995596
Book value: 1909700000
P/B ratio: 0.619774480871341
Market cap (USD): 1183583326.12
Debt to equity: 0.34256689532387286
Current ratio: 2.263379204892966
Quick ratio: 1.4107415902140672
Effective tax rate (%): -14.908256880733944
Interest coverage ratio: 4.976666666666667
COGS to revenue (%): 63.26450694197223
SG&A to revenue (%): 31.420434318262725
Free cash flow (dilution-adjusted): 144800000
Buyback yield (%): 27.577272575307244
Retained earnings: 2219300000
Inventory turnover: 3.983635956063663
Receivables turnover: 4.905693328676214
Capitalized R&D asset: 7425000
ROCI (R&D-adjusted, %): 4.951419866786553
FCF margin (%): 5.154859380562478
Revenue growth (%): -5.226222207226964
Rule of 40 score: -0.07136282666448679
Financial ratios for SPB — quarterly report dated 2025-12-31
Total revenue: 677000000
Gross profit: 241600000
Operating income: 30900000
Net income: 28400000
Capital expenditures: 8100000
Operating cash flow: 67400000
Depreciation & amortization: 25800000
Net tangible assets: 102800000
Owner earnings: 46100000
Return on net tangible assets (%): 44.8443579766537
Capex to operating income (%): 26.21359223300971
Buffett classification: The Good
Stock price: 58.36
P/E ratio: 12.756872457794676
Shares outstanding: 22995596
Book value: 1899300000
P/B ratio: 0.7065882075290897
Market cap (USD): 1342022982.56
Debt to equity: 0.3672932132891065
Current ratio: 2.214680929546293
Quick ratio: 1.383253412025083
Effective tax rate (%): -43.41463414634146
Interest coverage ratio: 4.544117647058823
COGS to revenue (%): 64.31314623338257
R&D to revenue (%): 0.7385524372230428
SG&A to revenue (%): 30.384047267355985
Free cash flow (dilution-adjusted): 55000000
Buyback yield (%): 2.645260212480217
Retained earnings: 2236400000
Inventory turnover: 0.9658385093167702
Receivables turnover: 1.1784160139251523
Capitalized R&D asset: 6815000
ROCI (R&D-adjusted, %): 1.1220720931319836
FCF margin (%): 8.124076809453472
Revenue growth (%): -7.702794819359236
Rule of 40 score: 0.4212819900942355
Financial ratios for TER.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.06015037593984962
Shares outstanding: 1822523150
Market cap (USD): 109625452.63157894
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TER.AX — annual report dated 2022-06-30
Total revenue: 554914482.7586207
Gross profit: 285848965.51724136
Operating income: 236078620.68965518
Net income: 148730344.8275862
Capital expenditures: 5277931.0344827585
Depreciation & amortization: 19009655.172413792
Net tangible assets: 100295172.4137931
Owner earnings: 162462068.96551725
Return on net tangible assets (%): 161.98393706851502
Capex to operating income (%): 2.235666668614196
Buffett classification: The Great
Stock price: 0.26896551724137935
P/E ratio: 3.295870000788282
Shares outstanding: 1822523150
Book value: 32826206.89655173
P/B ratio: 14.93306501323585
Market cap (USD): 490195881.724138
Debt to equity: 1.0806966679272236
Current ratio: 0.6490716648291069
Quick ratio: 0.5961058434399118
Effective tax rate (%): 32.62614302718273
Interest coverage ratio: 9.077298400997057
COGS to revenue (%): 48.487744616753616
SG&A to revenue (%): 3.520641888281015
Free cash flow (dilution-adjusted): 210880000
Buyback yield (%): 0
Retained earnings: -185322758.62068966
Inventory turnover: 32.48501248959201
Receivables turnover: 12.266575196280204
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 135.02978186264843
FCF margin (%): 38.002251977937576
Rule of 40 score: 38.002251977937576
Financial ratios for TER.AX — annual report dated 2023-06-30
Total revenue: 437509271.5231788
Gross profit: 230709933.77483442
Operating income: 208061589.40397352
Net income: 173836423.8410596
Capital expenditures: 7086754.966887417
Depreciation & amortization: 9492715.23178808
Net tangible assets: 110816556.29139073
Owner earnings: 176242384.10596025
Return on net tangible assets (%): 159.03975904334467
Capex to operating income (%): 3.406085182367676
Buffett classification: The Great
Stock price: 0.25165562913907286
P/E ratio: 2.638389583722233
Shares outstanding: 1822523150
Book value: 111158278.14569534
P/B ratio: 4.1260823537822695
Market cap (USD): 458648209.9337748
Debt to equity: 0.043324654898152515
Current ratio: 0.6914251579067581
Quick ratio: 0.5546809800321524
Effective tax rate (%): 27.28927176532506
Interest coverage ratio: 136.5375923511517
COGS to revenue (%): 47.26741836313024
SG&A to revenue (%): 1.4749356305031947
Free cash flow (dilution-adjusted): 126419867.54966888
Buyback yield (%): 0
Retained earnings: -153380794.70198676
Inventory turnover: 20.06083772324296
Receivables turnover: 34.57213878277252
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 129.62483135358607
FCF margin (%): 28.895357373694257
Revenue growth (%): -21.157352147630178
Rule of 40 score: 7.738005226064079
Financial ratios for TER.AX — annual report dated 2024-06-30
Total revenue: 172762000
Gross profit: 38572000
Operating income: 16168666.666666666
Net income: 17300666.666666668
Capital expenditures: 8343333.333333333
Depreciation & amortization: 11564000
Net tangible assets: 112173333.33333333
Owner earnings: 20521333.333333336
Return on net tangible assets (%): 18.294306430524195
Capex to operating income (%): 51.60186368696657
Buffett classification: The Good
Stock price: 0.13999999999999999
P/E ratio: 14.748173923933566
Shares outstanding: 1822523150
Book value: 113741333.33333334
P/B ratio: 2.2432763316765523
Market cap (USD): 255153240.99999997
Debt to equity: 0.024476590157784913
Current ratio: 0.6460148028800161
Quick ratio: 0.5314561200342379
Effective tax rate (%): 24.823610652415407
Interest coverage ratio: 5.581818181818182
COGS to revenue (%): 77.6733309408319
SG&A to revenue (%): 3.0855550796278504
Free cash flow (dilution-adjusted): -18715333.333333332
Buyback yield (%): 0
Retained earnings: -153122666.66666666
Inventory turnover: 22.116800351609715
Receivables turnover: 11.077327519876892
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.201523519489859
FCF margin (%): -10.833014976287222
Revenue growth (%): -60.51237968088472
Rule of 40 score: -71.34539465717194
Financial ratios for THRM — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 86.9
Shares outstanding: 30666983
Market cap (USD): 2664960822.7000003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for THRM — annual report dated 2022-12-31
Total revenue: 1204656000
Gross profit: 273650000
Operating income: 55235000
Net income: 24441000
Capital expenditures: 39455000
Operating cash flow: 14947000
Depreciation & amortization: 44394000
Net tangible assets: 478566000
Owner earnings: 29380000
Return on net tangible assets (%): 6.139174116004898
Capex to operating income (%): 71.43115778039287
Buffett classification: The Good
Stock price: 65.29
P/E ratio: 81.92166114602513
Shares outstanding: 30666983
Book value: 672273000
P/B ratio: 2.9783247580521603
Market cap (USD): 2002247320.0700002
Debt to equity: 0.39087840802769114
Current ratio: 2.394282713347921
Quick ratio: 1.6301759299781182
Effective tax rate (%): 36.32171330311083
Interest coverage ratio: 12.863297624592455
COGS to revenue (%): 77.28397152382091
R&D to revenue (%): 7.115890345459616
SG&A to revenue (%): 11.015011754392956
Free cash flow (dilution-adjusted): -31850000
Buyback yield (%): 0
Retained earnings: 590657000
Inventory turnover: 4.265816868883105
Receivables turnover: 4.30558742480941
Capitalized R&D asset: 85722000
ROCI (R&D-adjusted, %): 10.812326762536355
FCF margin (%): -2.6439083024531485
Rule of 40 score: -2.6439083024531485
Financial ratios for THRM — annual report dated 2023-12-31
Total revenue: 1469076000
Gross profit: 351624000
Operating income: 101687000
Net income: 40343000
Capital expenditures: 37211000
Operating cash flow: 119265000
Depreciation & amortization: 50948000
Net tangible assets: 474167000
Owner earnings: 54080000
Return on net tangible assets (%): 11.40526438997231
Capex to operating income (%): 36.59366487358266
Buffett classification: The Good
Stock price: 52.36
P/E ratio: 39.80178047938924
Shares outstanding: 30666983
Book value: 644722000
P/B ratio: 2.490566833270774
Market cap (USD): 1605723229.8799999
Debt to equity: 0.38266570707995073
Current ratio: 2.1158875283502536
Quick ratio: 1.4822820530969094
Effective tax rate (%): 26.587691523819924
Interest coverage ratio: 6.945358923570795
COGS to revenue (%): 76.0649551146435
R&D to revenue (%): 6.422948846758099
SG&A to revenue (%): 10.590262178403295
Free cash flow (dilution-adjusted): 69221000
Buyback yield (%): 5.673082278744121
Retained earnings: 624379000
Inventory turnover: 5.427369688963146
Receivables turnover: 5.026881646843049
Capitalized R&D asset: 151791740
ROCI (R&D-adjusted, %): 12.817290325033518
Rosenberg metric: 0.9096148013345465
FCF margin (%): 4.711873313565806
Revenue growth (%): 21.94983464159063
Rule of 40 score: 26.661707955156437
Financial ratios for THRM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 46.55
Shares outstanding: 30666983
Market cap (USD): 1427548058.6499999
Buyback yield (%): 1.3922473488419957
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for THRM — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 39.92
Shares outstanding: 30666983
Market cap (USD): 1224225961.3600001
Buyback yield (%): 0.8174144574489469
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for THRM — annual report dated 2024-12-31
Total revenue: 1456124000
Gross profit: 366431000
Operating income: 122626000
Net income: 64947000
Capital expenditures: 65452000
Operating cash flow: 109646000
Depreciation & amortization: 52975000
Net tangible assets: 460093000
Owner earnings: 52470000
Return on net tangible assets (%): 11.404216104135468
Capex to operating income (%): 53.37530376918435
Buffett classification: The Good
Stock price: 39.92
P/E ratio: 18.849615245661848
Shares outstanding: 30666983
Book value: 616947000
P/B ratio: 1.9843292233530596
Market cap (USD): 1224225961.3600001
Debt to equity: 0.42916166218492025
Current ratio: 2.010076610450406
Quick ratio: 1.3419582536226136
Effective tax rate (%): 36.491468244267345
Interest coverage ratio: 8.014771241830065
COGS to revenue (%): 74.83517887212902
R&D to revenue (%): 6.091308157821724
SG&A to revenue (%): 10.652114792421525
Free cash flow (dilution-adjusted): 24945000
Buyback yield (%): 4.213682900719888
Retained earnings: 695801000
Inventory turnover: 4.792893083974032
Receivables turnover: 5.003449887294519
Capitalized R&D asset: 180205120
ROCI (R&D-adjusted, %): 11.193952671152022
Rosenberg metric: 0.1569236312766273
FCF margin (%): 1.7131095978089779
Revenue growth (%): -0.8816426107294653
Rule of 40 score: 0.8314669870795126
Financial ratios for THRM — quarterly report dated 2025-03-31
Total revenue: 353854000
Gross profit: 86465000
Operating income: 23771000
Net income: -128000
Capital expenditures: 11128000
Operating cash flow: -13344000
Depreciation & amortization: 12931000
Net tangible assets: 487809000
Owner earnings: 1675000
Capex to operating income (%): 46.813343990576755
Buffett classification: The Good
Stock price: 26.74
Shares outstanding: 30666983
Book value: 646528000
P/B ratio: 1.2683675346156702
Market cap (USD): 820035125.42
Debt to equity: 0.4988213967531182
Current ratio: 2.163021260934802
Quick ratio: 1.4949353112702772
Effective tax rate (%): 106.14203454894434
Interest coverage ratio: 6.686638537271449
COGS to revenue (%): 75.56478095485708
R&D to revenue (%): 6.843500426729668
SG&A to revenue (%): 10.873976272700041
Free cash flow (dilution-adjusted): -30986000
Buyback yield (%): 0
Retained earnings: 695673000
Inventory turnover: 1.133061850602573
Receivables turnover: 1.089995625897153
Capitalized R&D asset: 24216000
ROCI (R&D-adjusted, %): 3.931613660719914
FCF margin (%): -8.75671887275543
Rule of 40 score: -8.75671887275543
Financial ratios for THRM — quarterly report dated 2025-06-30
Total revenue: 375090000
Gross profit: 89762000
Operating income: 26117000
Net income: 477000
Capital expenditures: 8855000
Operating cash flow: 45045000
Depreciation & amortization: 13158000
Net tangible assets: 534778000
Owner earnings: 4780000
Return on net tangible assets (%): 0.8938288411265984
Capex to operating income (%): 33.905119270972925
Buffett classification: The Good
Stock price: 28.29
P/E ratio: 2485.8709142406874
Shares outstanding: 30666983
Book value: 699745000
P/B ratio: 1.2398358674517147
Market cap (USD): 867568949.0699999
Debt to equity: 0.3861320909759984
Current ratio: 2.0131723817735625
Quick ratio: 1.35419778470518
Effective tax rate (%): 81.17600631412786
Interest coverage ratio: 6.459807073954984
COGS to revenue (%): 76.06921005625317
R&D to revenue (%): 6.014023301074409
SG&A to revenue (%): 10.953904396278226
Free cash flow (dilution-adjusted): 31765000
Buyback yield (%): 0
Retained earnings: 696150000
Inventory turnover: 1.1487374388044318
Receivables turnover: 1.135078210819693
Capitalized R&D asset: 38782720
ROCI (R&D-adjusted, %): 3.2331673329562896
Rosenberg metric: 0.13614965312190289
FCF margin (%): 8.468634194459996
Revenue growth (%): 6.001345187563232
Rule of 40 score: 14.46997938202323
Financial ratios for THRM — quarterly report dated 2025-09-30
Total revenue: 386870000
Gross profit: 95148000
Operating income: 27844000
Net income: 14949000
Capital expenditures: 9625000
Operating cash flow: 56119000
Depreciation & amortization: 13389000
Net tangible assets: 554927000
Owner earnings: 18713000
Return on net tangible assets (%): 3.3721552564571557
Capex to operating income (%): 34.567590863381696
Buffett classification: The Good
Stock price: 34.06
P/E ratio: 68.27803902340176
Shares outstanding: 30666983
Book value: 717948000
P/B ratio: 1.4548650333728905
Market cap (USD): 1044517440.98
Debt to equity: 0.34677720392006106
Current ratio: 1.9631349528508086
Quick ratio: 1.3305164553800037
Effective tax rate (%): 28.418885271020876
Interest coverage ratio: 8.40446725022638
COGS to revenue (%): 75.40569183446635
R&D to revenue (%): 6.314524258794944
SG&A to revenue (%): 11.082534184609818
Free cash flow (dilution-adjusted): 42175000
Buyback yield (%): 0
Retained earnings: 711099000
Inventory turnover: 1.1518994839152943
Receivables turnover: 1.1913809881622548
Capitalized R&D asset: 47534140
ROCI (R&D-adjusted, %): 2.77466620602852
Rosenberg metric: 0.23876230162248427
FCF margin (%): 10.901594850983534
Revenue growth (%): 3.1405795942307178
Rule of 40 score: 14.04217444521425
Financial ratios for THRM — annual report dated 2025-12-31
Total revenue: 1498602000
Gross profit: 362176000
Operating income: 97372000
Net income: 18285000
Capital expenditures: 51903000
Operating cash flow: 116791000
Depreciation & amortization: 53379000
Net tangible assets: 558609000
Owner earnings: 19761000
Return on net tangible assets (%): 3.537536989199959
Capex to operating income (%): 53.30382450807214
Buffett classification: The Good
Stock price: 36.37
P/E ratio: 60.998532770576965
Shares outstanding: 30666983
Book value: 720323000
P/B ratio: 1.5484139361231002
Market cap (USD): 1115358171.71
Debt to equity: 0.3426573911981153
Current ratio: 1.9216690163488412
Quick ratio: 1.2966486112141673
Effective tax rate (%): 48.97446630389285
Interest coverage ratio: 7.0503222069364995
COGS to revenue (%): 75.83240913865056
R&D to revenue (%): 6.323159851648404
SG&A to revenue (%): 11.34690865219718
Free cash flow (dilution-adjusted): 47578000
Buyback yield (%): 0.8979178396698886
Retained earnings: 714086000
Inventory turnover: 4.4970993502227925
Receivables turnover: 4.7066793551487285
Capitalized R&D asset: 185324130
ROCI (R&D-adjusted, %): 8.452750778148694
Rosenberg metric: -0.04797231022469756
FCF margin (%): 3.1748256041297154
Revenue growth (%): 2.917196612376418
Rule of 40 score: 6.092022216506134
Financial ratios for THRM — quarterly report dated 2025-12-31
Total revenue: 382788000
Gross profit: 90801000
Operating income: 19640000
Net income: 2987000
Capital expenditures: 22295000
Operating cash flow: 28971000
Depreciation & amortization: 13901000
Net tangible assets: 558609000
Owner earnings: -5407000
Return on net tangible assets (%): -0.9679400081273305
Capex to operating income (%): 113.51832993890021
Buffett classification: The Gruesome
Stock price: 36.37
P/E ratio: 60.998532770576965
Shares outstanding: 30666983
Book value: 720323000
P/B ratio: 1.5484139361231002
Market cap (USD): 1115358171.71
Debt to equity: 0.3426573911981153
Current ratio: 1.9216690163488412
Quick ratio: 1.2966486112141673
Effective tax rate (%): 71.09261589083519
Interest coverage ratio: 6.772413793103448
COGS to revenue (%): 76.27903696040627
R&D to revenue (%): 6.153797924699834
SG&A to revenue (%): 12.43638776555169
Free cash flow (dilution-adjusted): 4624000
Buyback yield (%): 0
Retained earnings: 714086000
Inventory turnover: 1.1554597905833748
Receivables turnover: 1.2022273939302572
Capitalized R&D asset: 47367570
ROCI (R&D-adjusted, %): 1.8934026888550053
Rosenberg metric: -0.17794424659216504
FCF margin (%): 1.207979351494822
Revenue growth (%): -1.0551347998035516
Rule of 40 score: 0.15284455169127042
Financial ratios for TTMI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.9
Shares outstanding: 103850059
Market cap (USD): 1547365879.1000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TTMI — annual report dated 2022-12-31
Total revenue: 2495046000
Gross profit: 457965000
Operating income: 162698000
Net income: 94583000
Capital expenditures: 96874000
Operating cash flow: 272873000
Depreciation & amortization: 133907000
Net tangible assets: 487105000
Owner earnings: 131616000
Return on net tangible assets (%): 27.020047012451116
Capex to operating income (%): 59.542219326605114
Buffett classification: The Good
Stock price: 15.08
P/E ratio: 16.557509168878127
Shares outstanding: 103850059
Book value: 1535579000
P/B ratio: 1.0198491186191008
Market cap (USD): 1566058889.72
Debt to equity: 0.6268664783772114
Current ratio: 1.9611282960627854
Quick ratio: 1.7369940564148032
Effective tax rate (%): 48.27657864084041
Interest coverage ratio: 3.574444712964387
COGS to revenue (%): 81.64502778706284
R&D to revenue (%): 0.9942902856300044
SG&A to revenue (%): 9.35301393240846
Free cash flow (dilution-adjusted): 150464000
Buyback yield (%): 2.2619839031936757
Retained earnings: 800841000
Inventory turnover: 11.93795673908075
Receivables turnover: 2.840919416159125
Capitalized R&D asset: 24808000
ROCI (R&D-adjusted, %): 6.928126756721619
FCF margin (%): 6.030510058732384
Rule of 40 score: 6.030510058732384
Financial ratios for TTMI — annual report dated 2023-12-31
Total revenue: 2232567000
Gross profit: 413268000
Operating income: 110768000
Net income: -18718000
Capital expenditures: 97968000
Operating cash flow: 187284000
Depreciation & amortization: 160731000
Net tangible assets: 571593000
Owner earnings: 44045000
Capex to operating income (%): 88.44431604795608
Buffett classification: The Gruesome
Stock price: 15.81
Shares outstanding: 103850059
Book value: 1511039000
P/B ratio: 1.0865830946719444
Market cap (USD): 1641869432.79
Debt to equity: 0.6749355906763492
Current ratio: 2.0308515534443963
Quick ratio: 1.7281813223027795
Effective tax rate (%): 6402.3569023569025
Interest coverage ratio: 2.3017205552323166
COGS to revenue (%): 81.48911096509086
R&D to revenue (%): 1.2215534852929386
SG&A to revenue (%): 10.147646184862538
Free cash flow (dilution-adjusted): 4155000
Buyback yield (%): 1.4880598610379834
Retained earnings: 782123000
Inventory turnover: 8.538303414290743
Receivables turnover: 3.1341135743404873
Capitalized R&D asset: 43893360
ROCI (R&D-adjusted, %): 4.530757332231816
Rosenberg metric: -1.8017171880038698
FCF margin (%): 0.18610863638134936
Revenue growth (%): -10.520006444770958
Rule of 40 score: -10.333897808389608
Financial ratios for TTMI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.25
Shares outstanding: 103850059
Market cap (USD): 1895263576.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TTMI — annual report dated 2024-12-31
Total revenue: 2442753000
Gross profit: 477375000
Operating income: 159843000
Net income: 56299000
Capital expenditures: 146134000
Operating cash flow: 236894000
Depreciation & amortization: 150125000
Net tangible assets: 701870000
Owner earnings: 60290000
Return on net tangible assets (%): 8.589909812358414
Capex to operating income (%): 91.4234592694081
Buffett classification: The Gruesome
Stock price: 24.75
P/E ratio: 45.65425603030249
Shares outstanding: 103850059
Book value: 1563824000
P/B ratio: 1.6435922202562436
Market cap (USD): 2570288960.25
Debt to equity: 0.6491804704365709
Current ratio: 1.9859539659899093
Quick ratio: 1.707869932044091
Effective tax rate (%): 32.936663926908004
Interest coverage ratio: 3.3640534568031146
COGS to revenue (%): 80.45750020571052
R&D to revenue (%): 1.303652067974126
SG&A to revenue (%): 10.239962861574625
Free cash flow (dilution-adjusted): 21375000
Buyback yield (%): 1.3414445042259524
Retained earnings: 838422000
Inventory turnover: 8.735595706380426
Receivables turnover: 2.943100724945873
Capitalized R&D asset: 58303880
ROCI (R&D-adjusted, %): 6.015003880526774
Rosenberg metric: 2.350652684071575
FCF margin (%): 0.8750373042219168
Revenue growth (%): 9.414543886028952
Rule of 40 score: 10.289581190250868
Financial ratios for TTMI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24.75
Shares outstanding: 103850059
Market cap (USD): 2570288960.25
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TTMI — quarterly report dated 2025-03-31
Total revenue: 648668000
Gross profit: 130972000
Operating income: 50974000
Net income: 32178000
Capital expenditures: 63220000
Operating cash flow: -10655000
Depreciation & amortization: 36087000
Net tangible assets: 734271000
Owner earnings: 5045000
Return on net tangible assets (%): 0.6870760250643154
Capex to operating income (%): 124.0240122415349
Buffett classification: The Gruesome
Stock price: 20.51
P/E ratio: 16.54829938226428
Shares outstanding: 103850059
Book value: 1587001000
P/B ratio: 1.3421319268796934
Market cap (USD): 2129964710.0900002
Debt to equity: 0.6425062114012531
Current ratio: 2.072300061736792
Quick ratio: 1.7494414913097618
Effective tax rate (%): 21.499841428606278
Interest coverage ratio: 4.446441032798325
COGS to revenue (%): 79.80908569561008
R&D to revenue (%): 1.2431629123064496
SG&A to revenue (%): 10.0274716804282
Free cash flow (dilution-adjusted): -82760000
Buyback yield (%): 0.8392157820889299
Retained earnings: 870600000
Inventory turnover: 2.097319283575801
Receivables turnover: 0.7418172503033401
Capitalized R&D asset: 8064000
ROCI (R&D-adjusted, %): 2.0884858273906306
FCF margin (%): -12.758452706160933
Rule of 40 score: -12.758452706160933
Financial ratios for TTMI — quarterly report dated 2025-06-30
Total revenue: 730621000
Gross profit: 148109000
Operating income: 63177000
Net income: 41530000
Capital expenditures: 60234000
Operating cash flow: 97804000
Depreciation & amortization: 36916000
Net tangible assets: 793414000
Owner earnings: 18212000
Return on net tangible assets (%): 2.29539685460554
Capex to operating income (%): 95.3416591481077
Buffett classification: The Gruesome
Stock price: 40.82
P/E ratio: 57.512880669398164
Shares outstanding: 103850059
Book value: 1636920000
P/B ratio: 2.5897169124819786
Market cap (USD): 4239159408.38
Debt to equity: 0.6277692251301225
Current ratio: 2.025301025789094
Quick ratio: 1.7228690201062393
Effective tax rate (%): 8.775398132894015
Interest coverage ratio: 5.694186570527265
COGS to revenue (%): 79.72834068552642
R&D to revenue (%): 0.9593209064617634
SG&A to revenue (%): 9.722551090100065
Free cash flow (dilution-adjusted): 28208000
Buyback yield (%): 0
Retained earnings: 912130000
Inventory turnover: 2.326892733453437
Receivables turnover: 0.7938728166680249
Capitalized R&D asset: 12411880
ROCI (R&D-adjusted, %): 2.358695275928821
Rosenberg metric: 2.125124007936508
FCF margin (%): 3.8608252431835384
Revenue growth (%): 12.63404391768979
Rule of 40 score: 16.49486916087333
Financial ratios for TTMI — quarterly report dated 2025-09-30
Total revenue: 752736000
Gross profit: 156736000
Operating income: 72415000
Net income: 53055000
Capital expenditures: 99233000
Operating cash flow: 141803000
Depreciation & amortization: 36805000
Net tangible assets: 867167000
Owner earnings: -9373000
Return on net tangible assets (%): -1.0808760019696322
Capex to operating income (%): 137.03376372298555
Buffett classification: The Gruesome
Stock price: 57.6
P/E ratio: 47.18855974061832
Shares outstanding: 103850059
Book value: 1701448000
P/B ratio: 3.515689811501733
Market cap (USD): 5981763398.400001
Debt to equity: 0.6026754858214886
Current ratio: 1.9394710357787148
Quick ratio: 1.6592167723703966
Effective tax rate (%): 14.16854059825603
Interest coverage ratio: 6.963650350995288
COGS to revenue (%): 79.17782595757343
R&D to revenue (%): 0.9349891595459762
SG&A to revenue (%): 9.351751477277558
Free cash flow (dilution-adjusted): 30742000
Buyback yield (%): 0
Retained earnings: 965185000
Inventory turnover: 2.3493517602399807
Receivables turnover: 0.7947681060569266
Capitalized R&D asset: 14395150
ROCI (R&D-adjusted, %): 2.547342593813267
Rosenberg metric: 1.2308460550720501
FCF margin (%): 4.084034774476045
Revenue growth (%): 3.0268771360253814
Rule of 40 score: 7.110911910501427
Financial ratios for TTMI — quarterly report dated 2025-12-31
Total revenue: 774320000
Gross profit: 165869000
Operating income: 80965000
Net income: 50685000
Capital expenditures: 69097000
Operating cash flow: 62930000
Depreciation & amortization: 37363000
Net tangible assets: 937196000
Owner earnings: 18951000
Return on net tangible assets (%): 2.0220956982317464
Capex to operating income (%): 85.34181436423147
Buffett classification: The Gruesome
Stock price: 69
P/E ratio: 40.3817122255534
Shares outstanding: 103850059
Book value: 1762253000
P/B ratio: 4.0661891743126555
Market cap (USD): 7165654071
Debt to equity: 0.5835785213587379
Current ratio: 1.9283015848105949
Quick ratio: 1.6684202923102025
Effective tax rate (%): 18.260547026190167
Interest coverage ratio: 6.542097608274079
COGS to revenue (%): 78.57875297034818
R&D to revenue (%): 0.8886506870544477
SG&A to revenue (%): 9.186770327513173
Free cash flow (dilution-adjusted): -18541000
Buyback yield (%): 0
Retained earnings: 1015870000
Inventory turnover: 2.4332492191780273
Receivables turnover: 0.7504940649209545
Capitalized R&D asset: 13909430
ROCI (R&D-adjusted, %): 2.796292723723032
Rosenberg metric: 1.297669792554703
FCF margin (%): -2.394488066949065
Revenue growth (%): 2.867406368235344
Rule of 40 score: 0.472918301286279